Companion animals now account for one-third of the world market for animal health
products. Sales were $4.5 billion in 2003 and Animal Pharm Reports forecast that
they will rise to $5.9 billion by the end of the decade. The sector attracts the
bulk of R&D investment, and there is a range of new products in companies’
development pipelines. At the same time, market leading products will come off-patent,
and generics companies are already planning launches of competitor brands.
This report analyses all aspects of this highly dynamic market, including:
Market sizes and profiles in the 10 leading national markets, accounting for
85% of the world market
Reviews of product sectors, including the products on the market, recent developments,
generic activity and future prospects
Market drivers, including investments in R&D, the next generation of generic
products and regulatory developments
Profiles of the 10 leading companion animal companies, accounting for two-thirds
of world sales
The most important companion animal health problems.
Order this report now!
Contents:
1 Companion Animal Health Problems
2 Companion Animal Products
3 The Market for Companion Animal Products
4 Market Drivers and Constraints
5 Company Profiles
Products for use in companion animals have been the main driver of growth in
an otherwise flat market for veterinary medicines over the past decade. This report
analyses the size and structure of the companion animal market, identifies major
product segments and the geographical spread of sales in the sector, and profiles
the businesses of leading companies involved in the market.
Chapter 1 of the study provides a brief overview of major health problems affecting
the three key companion animal species (dogs, cats and horses), and identifies
the type of products used to prevent, treat or control them. Viral, bacterial
and parasitic infections are among the most prevalent challenges faced by companion
animals. Chronic, often age-related, conditions such as cardiovascular disease
and cancer are increasingly prevalent in dogs and cats, however, as the longevity
of pets continues to rise, with cancer now the leading disease-related cause of
mortality in the US canine population.
Products used to prevent, treat or control disease in companion animals are addressed
in Chapter 2 of the report. The main focus of this section is product groupings
responsible for major shares of the companion animal market in value terms, including
antiparasitics, anti-infectives, anti inflammatories and biologicals. Smaller
segments in which significant launch activity has been witnessed recently or is
expected in future are also addressed.
